Momentus Inc. (MNTS) Prices 800K Share Offering at $6.20/sh

Momentus Inc. (NASDAQ: MNTS) (“Momentus” or the “Company”), a U.S. commercial space company that offers satellite buses, transportation, and other in-space infrastructure services, today announced the pricing of its “reasonable best efforts” offering with a single institutional investor for the purchase and sale of 800,000 shares of common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 800,000 shares of common stock at a combined offering price of $6.20 per share and accompanying warrant, priced at-the-market under Nasdaq rules (the “Offering”). The Company expects to receive aggregate gross proceeds of approximately $5 million, before deducting placement agent fees and other Offering expenses, and assuming no exercise of the warrants. The warrants will have an exercise price of $6.08 per share, will be exercisable immediately and will expire five years from the issuance date.

The closing of the Offering is expected to occur on or about December 18, 2024, subject to the satisfaction of customary closing conditions.

The Company intends to use the net proceeds from the Offering for general corporate purposes, including repayment of debt.

A.G.P./Alliance Global Partners is acting as the sole placement agent for the Offering.

The securities described above are being offered pursuant to a registration statement on Form S-1 (File No. 333- 283539) previously filed with the Securities and Exchange Commission (“SEC”) which was declared effective on December 17, 2024. This Offering is being made only by means of a prospectus forming part of the effective registration statement. Copies of the preliminary prospectus and, when available, copies of the final prospectus, relating to the Offering may be obtained on the SEC’s website located at http://www.sec.gov. Electronic copies of the final prospectus relating to the Offering may be obtained, when available, from A.G.P./Alliance Global Partners, 590 Madison Avenue, 28th Floor, New York, NY 10022, or by telephone at (212) 624-2060, or by email at [email protected].

This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

You May Also Be Interested In

• enVVeno Medical (NVNO) files $100M mixed shelf
• Aveanna Healthcare prices secondary offering at $11.75 per share
• Sky Century Investment responds to OTC Markets stock promotion inquiry